Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2012
03/14/2012CN101843629B New application of icariin and epimedium flavone containing icariin
03/14/2012CN101712658B 1-butyl-2-hydroxy aralkyl piperazine derivative and application as antidepressant
03/14/2012CN101708238B Preparation method of qingkailing syrup
03/14/2012CN101575336B N-aryl piperazine derivative and preparation method thereof and drug composition adopting N-aryl piperazine derivative as active ingredient
03/14/2012CN101564388B Composition for Danshensu and danshinolic acid B and use thereof
03/14/2012CN101563328B Substituted heteroaryl pyridopyrimidone derivatives
03/14/2012CN101506201B Novel heteroaryl substituted benzoxazoles
03/14/2012CN101484448B Pyrazole alkanamide substituted thiophenes as AMPA potentiators
03/14/2012CN101426790B Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
03/14/2012CN101422595B Traditional Chinese medicine composition for treating dizziness and preparation method and quality control method thereof
03/14/2012CN101360502B Crystalline forms
03/14/2012CN101291933B Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
03/14/2012CN101219188B Anti-inflammation antalgica liquid
03/14/2012CN101098686B Glycogen synthase kinase-3 inhibitors
03/13/2012USRE43244 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
03/13/2012US8134003 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
03/13/2012US8133980 Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof
03/13/2012US8133972 IgE antigenic peptides
03/13/2012US8133728 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133726 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012CA2685952C N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain
03/13/2012CA2676670C Tricyclic compounds, compositions, and methods
03/13/2012CA2536499C Buccal formulations of galanthamine and uses thereof
03/13/2012CA2524366C Benzothiazole derivatives as adenosine receptor ligands
03/13/2012CA2514037C Crystalline modification of 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-n-methyl-isobutyramide
03/13/2012CA2503810C Therapeutic agent for fibromyalgia
03/13/2012CA2486539C C-aryl glucoside sglt2 inhibitors and method
03/13/2012CA2480468C Fredericamycin derivatives
03/13/2012CA2467159C Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
03/13/2012CA2442854C Hsa-free formulations of interferon-beta
03/13/2012CA2407238C The use of thymosin alpha 1 to reduce the side effects of chemotherapy in cancer patients
03/13/2012CA2369074C Ether compounds, compositions, and uses thereof
03/08/2012WO2012031220A2 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
03/08/2012WO2012031028A2 Methods for treating neurodegenerative diseases
03/08/2012WO2012030745A1 MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS
03/08/2012WO2012030258A1 Heterocyclic low-molecular sapp mimetics, a pharmaceutical composition and methods for producing and using same
03/08/2012WO2012030050A2 Pharmaceutical composition for prevention or treatment of degenerative neurological brain disorders
03/08/2012WO2012029991A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029655A1 Agent for controlling hemodialysis-induced cramps
03/08/2012WO2012029326A1 3-pyrazolyl-2-pyridone derivative
03/08/2012WO2012029070A1 Heterocyclyl compounds as histamine h3 receptor ligands
03/08/2012WO2012028959A1 Agonists of neurotrophin receptors and their use as medicaments
03/08/2012WO2012028874A1 Cytotoxic luminescent metal complexes
03/08/2012WO2012028635A1 Deuterated analogs of pridopidine useful as dopaminergic stabilizers
03/08/2012WO2012028331A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012WO2012028300A1 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
03/08/2012WO2012027882A1 Pharmaceutical composition for treating insomnia and preparation method thereof
03/08/2012WO2012027875A1 Pharmaceutical composition for treating mild cognitive impairment
03/08/2012WO2012027825A1 Method of treating dopamine-related neuropsychiatric disorders
03/08/2012WO2012027821A1 A trkc receptor agonist antibody to treat neurodegenerative and motor neuron diseases
03/08/2012WO2012010675A3 Bhlh proteins and their use as drugs
03/08/2012WO2012007877A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2012007869A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2012007868A3 N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
03/08/2012WO2012003912A8 Bipyridyl derivatives useful for the treatment of kinase - induced diseases
03/08/2012WO2011162989A3 Glp-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
03/08/2012WO2011126324A3 Pomegranate extract having a high ellagic acid content, and use of the pomegranate extract
03/08/2012WO2011122872A3 Composition comprising coumestrol or a bean extract containing coumestrol
03/08/2012WO2010124121A8 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitor
03/08/2012WO2003032894A3 Method of monitoring neuroprotective treatment
03/08/2012US20120059065 Tamper Resistant Dosage Form Comprising An Anionic Polymer
03/08/2012US20120059064 Compositions and Methods For Inhibiting an Isoform of Human Manganese Superoxide Dismutase
03/08/2012US20120059058 Dispersions of rasagiline citrate
03/08/2012US20120059054 Use Of Copolymers Based On Amino-Containing Polymers As Matrix Binders In Preparing Active Compound-Containing Granules And Administration Forms
03/08/2012US20120059053 Compounds of 2,3-dihydro-benzofuran
03/08/2012US20120059044 Methods of utilizing the arrestin-2/stam-1 complex as a therapeutic target
03/08/2012US20120059040 NOVEL FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID MAGNESIUM
03/08/2012US20120059037 Substituted pyridine derivatives and their medical use
03/08/2012US20120059034 Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
03/08/2012US20120059030 Heterocyclic compound and use thereof
03/08/2012US20120059024 Drug abuse deterrent, methods and compositions
03/08/2012US20120059017 CGRP Receptor Antagonist
03/08/2012US20120059016 Piperidine and piperazine derivatives as autotaxin inhibitors
03/08/2012US20120059013 Method of treating early morning akinesia in subjects having parkinson's disease
03/08/2012US20120059010 Alpha-helix mimetics and methods relating to the treatment of fibrosis
03/08/2012US20120059008 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
03/08/2012US20120059007 Pharmacologically-active vanilloid carbamates
03/08/2012US20120059006 Sigma receptor inhibitors
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120058999 Substituted Tetrahydropyrrolopyrazine Compounds
03/08/2012US20120058998 Compounds, Compositions and Methods for the Treatment of Inflammatory Diseases
03/08/2012US20120058996 Carbazole carboxamide compounds useful as kinase inhibitors
03/08/2012US20120058995 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants
03/08/2012US20120058994 Novel compounds
03/08/2012US20120058993 Stable Suspension Formulation
03/08/2012US20120058992 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of angiogenesis
03/08/2012US20120058987 Therapeutic uses of quinazolinedione derivatives
03/08/2012US20120058986 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012US20120058985 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058966 Sphingosine Kinase Inhibitor Prodrugs
03/08/2012US20120058951 Neurotensin receptor agonists and opioid receptor agonists
03/08/2012US20120058949 Methods of Treating Neurological Disorders
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/08/2012US20120058944 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058940 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058939 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 1833